Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors

The proteasome is a promising target for antimalarial chemotherapy. We assessed susceptibilities of fresh Plasmodium falciparum isolates from eastern Uganda to seven proteasome inhibitors: two asparagine ethylenediamines, two macrocyclic peptides, and three peptide boronates; five had median IC valu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial agents and chemotherapy 2022-10, Vol.66 (10), p.e0081722-e0081722
Hauptverfasser: Garg, Shreeya, Kreutzfeld, Oriana, Chelebieva, Sevil, Tumwebaze, Patrick K, Byaruhanga, Oswald, Okitwi, Martin, Orena, Stephen, Katairo, Thomas, Nsobya, Samuel L, Conrad, Melissa D, Aydemir, Ozkan, Legac, Jennifer, Gould, Alexandra E, Bayles, Brett R, Bailey, Jeffrey A, Duffey, Maelle, Lin, Gang, Kirkman, Laura A, Cooper, Roland A, Rosenthal, Philip J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The proteasome is a promising target for antimalarial chemotherapy. We assessed susceptibilities of fresh Plasmodium falciparum isolates from eastern Uganda to seven proteasome inhibitors: two asparagine ethylenediamines, two macrocyclic peptides, and three peptide boronates; five had median IC values
ISSN:0066-4804
1098-6596
DOI:10.1128/aac.00817-22